India holds a unique position in the generic market. Commonly referred to as the “pharmacy of the developing world”, India exports huge volumes of generic medication. This forms a multi-billion dollar industry within India. This low cost generics market has improved access to lower price medications in India, as well as allowed for the export … [Read more...] about Indian patent laws, no longer the pharmacy of the developing world?
india
What India will really do about access to innovative medicines
Recent controversy about access and IP Will India risk the wrath of many of its trading partners by issuing more compulsory licences to give access to innovative medicines? The question has flared to life again over the past few weeks. In early March, US trade groups sounded triumphal: India had assured the Americans that it would respect the … [Read more...] about What India will really do about access to innovative medicines
India’s new medicine taxes hit the poor and the sick
India surprised the world this week by announcing that it would impose taxes on many imported medicines. It will remove customs duty waivers and impose excise duty on 76 medicines used to treat cancer, HIV, haemophilia, diabetes and other diseases. The Times of India reported that this might “result in price increases between 10-25 percent on both … [Read more...] about India’s new medicine taxes hit the poor and the sick
Business travellers matter more than sick people say developing country governments
If, like me, you travel a lot to India and Africa, I have good news: business class fares are going to stay low or even fall in 2014. This is thanks to generous subsidies from the governments of some of the countries with the highest burdens of disease in the world. This October 2013 article from CAPA, the Centre for Aviation, lists the $2.5 … [Read more...] about Business travellers matter more than sick people say developing country governments
Reasons #polio may not be eradicated by 2018: a journal trips over itself #GPEI
An article in the current PLoS Medicine is sure to ruffle feathers amongst those committed to polio eradication by questioning whether polio can or should be eradicated by 2018. An independent expert board has concluded that there is a realistic prospect of no new transmission by 2014 but the authors of the PLoS paper think that even 2018 is too … [Read more...] about Reasons #polio may not be eradicated by 2018: a journal trips over itself #GPEI
India’s policy in #greenenergy and #cleantech #patents is “expropriation” says newspaper
India apparently plans to force the holders of green energy patents to license their innovations to Indian companies. As we noted earlier this week, this seems a bold extension of a policy that has already had a limited use in the health and pharma sector. India can do this under the National Manufacturing Policy. The NMP says that the government … [Read more...] about India’s policy in #greenenergy and #cleantech #patents is “expropriation” says newspaper
India may start seizing #patent rights for #greenenergy
There is a long and complicated tussle over patents in the pharma sector in India. Over the year, India has issued two compulsory licences for pharmaceuticals and made a number of other moves seen as hostile to patent holders (see this recent article on our sister site, Health Issues India) Now, according to Business Line (part of the respected … [Read more...] about India may start seizing #patent rights for #greenenergy
India’s patent system on medicine may be the new normal #accesstomedicine #india
There has been a lot of wailing amongst multinational pharma companies about India's uniquely unfriendly attitude to patents. Now, it might be starting to look like the new normal. The MNC's are worried about three separate developments in India that they think will reduce incentives for innovation Compulsory licences where a local … [Read more...] about India’s patent system on medicine may be the new normal #accesstomedicine #india
The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
